US Patent Issued to ELI LILLY and Co. on Dec. 16 for "Methods of using and compositions including an incretin analog" (Austrian, American Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,496,329, issued on Dec. 16, was assigned to ELI LILLY AND COMPANY (Indianapolis).

"Methods of using and compositions including an incretin analog" was invented by Tamer Coskun (Indianapolis), Zvonko Milicevic (Vienna) and Shweta Urva (Indianapolis).

According to the abstract* released by the U.S. Patent & Trademark Office: "Doses and dosing regimens for incretin analogs are disclosed comprising determining and administering doses of long-acting incretin analogs suitable for once-weekly dosing, such as a glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon (GCG) (GGG) tri-receptor agonist."

The patent was filed on June 22, 2022, under Appli...